Lars Rose nominated as next MVFP chair
MVFP has nominated Lars Joachim Rose as candidate for chair of its board. He is set to succeed Philipp Welte, who will not seek re-election in 2026.
MVFP has nominated Lars Joachim Rose as candidate for chair of its board. He is set to succeed Philipp Welte, who will not seek re-election in 2026.
Pierre Fabre appoints Özgül Gebel as Commercial Sales Director. She will expand wholesaler and e-commerce ties, while keeping pharmacies central.
PGEU’s General Assembly has elected German pharmacist Mathias Arnold as president for 2027. He will succeed Poland’s Dr Mikolaj Konstanty.
Orifarm has appointed Pierre Bourdage to its Board of Directors, effective May 1. The former Sandoz CCO brings international pharma expertise.
SCHOTT Pharma appoints Christian Mias as CEO effective 1 May 2026. Andreas Reisse will retire as planned at the end of April 2026.
Friso Janßen has been appointed CEO of the German Heart Foundation effective 4 May 2026, succeeding Martin Vestweber and focusing on prevention and research.
Sanofi has confirmed Belén Garijo as CEO from May 1, 2026. Shareholders also approved a dividend of €4.12 per share, payable May 7.
rheingold Institut appoints Jana Baum as CEO effective May 1, forming a new C-level trio with COO Judith Barbolini and CSO Paul Bremer.
Charité will split corporate communications into Brand & Corporate Identity and Media & Politics from 1 May 2026 and appoints new heads.
Evotec names Dr. Ingrid Müller COO and Management Board member from 1 May 2026. She will lead global operations and the Horizon transformation.
CompuGroup Medical appoints Thorsten Herrmann as Managing Director for Germany, effective April 1, 2026, covering all customer segments.
Jenoptik’s Supervisory Board has appointed Dr. Dominic Dorfner as future CEO. He is expected to take office no later than 1 October 2026.
Stefan Betzold is leaving Bauer Media Group. The Managing Director of Bauer Xcel Media will support the transition of responsibilities.
Dr. Christopher Kirsch (Sandoz/Hexal) has been appointed chair of Pro Biosimilars. Dominic Fister (STADAPHARM) will serve as deputy chair.
Sanacorp names Manuel Kuhn as Board member for Trade from 1 July 2026. He succeeds Frank Hennings and will oversee sales, purchasing and mea.
Medicos Kosmetik has launched a Transformation Office for Dermasence. Christian Mies-Mäkelä has led the new unit since March 2026.
BioNTech says co-founders Ugur Sahin and Özlem Türeci plan a new independent next-gen mRNA company. Management transition is expected by end of 2026.
Ipsen has appointed Peter Guenter to its Board of Directors effective 28 January 2026. He fills the vacancy created by Henri Beaufour’s seat.
Novo Nordisk employees have elected new representatives to the Board of Directors. The new term starts after the AGM on 26 March 2026.
Essity names Niklas Westin Sundberg as CDIO, succeeding Carl-Magnus Månsson. He joins the Executive Management Team on April 15, 2026.